Heo Nae Yun, Lim Young Suk, Kang Jeong Min, Oh Se Il, Park Chan Sun, Jung Seok Won, Lee Yoon Sun, Kim Kang Mo, Lee Han Chu, Chung Young Hwa, Lee Yung Sang, Suh Dong Jin
Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Korean J Hepatol. 2006 Mar;12(1):82-92.
BACKGROUND/AIMS: Striking geographic differences have been noted in the etiology of fulminant hepatic failure (FHF). The prognosis of patients with FHF who do not receive liver transplantation in a timely manner is quite dismal. This study intended to identify the etiology and outcome of FHF in Korean adults and to examine the role of urgent living-donor liver transplantation (LDLT) for treating this unique situation.
We identified all the adult FHF patients who were referred to our unit between 1999 and 2004. FHF was defined as severe acute hepatitis complicated by the rapid development of hepatic encephalopathy within 8 weeks of the initial symptoms in the patients without a previous history of liver disease.
One hundred fourteen patients (47 males and 67 females) were identified. The mean age was 39.5+/-15.3 years. Drugs were the most common cause (28.1%) of FHF (herbal medications, 9.6%), and acute viral infection accounted for 23.7% (HBV accounted for 15.8%). Indeterminate etiologies were noted in 34%. The 90-day survival rate of the nontransplant group was only 15%. Fourteen patients received liver transplants (13 right-lobe LDLT, 1 cadaveric whole liver), and 12 of these (85.7%) survived and showed good graft function during 22 months of median follow-up.
Although the causes of FHF in Korea were diverse, HBV infection and herbal medications were responsible for a significant proportion of the cases. Since urgent LDLT improved the overall survival rate of patients with FHF, this should be considered as an important treatment option for patients suffering with FHF.
背景/目的:暴发性肝衰竭(FHF)的病因存在显著的地域差异。未及时接受肝移植的FHF患者预后相当不佳。本研究旨在确定韩国成年人FHF的病因及预后,并探讨紧急活体肝移植(LDLT)在治疗这种特殊情况中的作用。
我们确定了1999年至2004年间转诊至我院的所有成年FHF患者。FHF被定义为在无既往肝病病史的患者中,初始症状出现8周内迅速发展为肝性脑病的严重急性肝炎。
共确定了114例患者(47例男性和67例女性)。平均年龄为39.5±15.3岁。药物是FHF最常见的病因(28.1%)(草药,9.6%),急性病毒感染占23.7%(乙肝病毒占15.8%)。34%的病因不明。非移植组的90天生存率仅为15%。14例患者接受了肝移植(13例右叶LDLT,1例尸体全肝),其中12例(85.7%)存活,在中位随访22个月期间移植肝功能良好。
虽然韩国FHF的病因多种多样,但乙肝病毒感染和草药导致了相当比例的病例。由于紧急LDLT提高了FHF患者的总体生存率,应将其视为FHF患者的一种重要治疗选择。